Investing

Outlook Therapeutics : OTLK

OTLK

Stock Data

$1.58

$0.07 (4.24%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company is headquartered in Cranbury, New Jersey.

All Outlook Therapeutics Articles

1 Article

Lee Jackson | Dec 27, 2023 at 9:15 AM EST

2 Red-Hot Stocks Highlight Wednesday’s Top Wall Street Upgrades and Downgrades

A quiet week so far with markets trading slightly higher and analyst ratings trickling in. Just enough action to keep…